LATENT TUBERCULOSIS
Clinical trials for LATENT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new LATENT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for LATENT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing study aims to protect kids from latent TB
Disease control CompletedThis study looked at how to best dose two medicines, rifapentine and isoniazid, for children aged 0-12 with latent (hidden) tuberculosis infection. The goal was to find a dose that works as well as in adults to prevent the infection from turning into active TB. The study included…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE1, PHASE2 • Sponsor: Centers for Disease Control and Prevention • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a 2-Month TB prevention be as good as 4 months?
Disease control CompletedThis study tested whether taking a higher dose of the drug rifampin for 2 months is as safe and effective as the standard 4-month dose for treating latent tuberculosis (TB) infection. Over 1,300 adults and children aged 10 and older with latent TB were randomly assigned to receiv…
Matched conditions: LATENT TUBERCULOSIS
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
3-Minute video aims to boost latent TB treatment completion
Knowledge-focused CompletedThis study tests whether a 3-minute educational video can help more people complete their treatment for latent tuberculosis (LTBI). About 1,898 adults at Kaiser Permanente Southern California are randomly assigned to receive the video or standard care. The main goal is to see if …
Matched conditions: LATENT TUBERCULOSIS
Phase: NA • Sponsor: Kaiser Permanente • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC